🇺🇸 AMGN — Amgen Inc.

Salud Mantener
← Volver

Precio actual

460,28 USD

Máx. histórico

478,48

1 días

Split 2:1 del 22/11/1999

Caída desde máximo

-3,80%

Rango 52 semanas

312,39 – 483,99

Variación hoy

-3,80%

Cierre anterior

478,48

Rango de hoy

459,65 – 483,99

Volumen hoy

4.073.505

Peor caída histórica

-78,03%

17/06/1983 → 19/11/1984

Recuperado en 487 días

Volatilidad anualizada ⓘ

37,46%

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
26,68 (puede no estar actualizado)
Dividend yield
2,11% (puede no estar actualizado)
Precio objetivo analistas
404,32 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 19 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,16%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/06/2019 175,83 177,45 175,23 176,71 +0,63% 1,26% 1.675.800
12/06/2019 175,30 176,69 174,16 175,60 +0,56% 1,44% 1.888.600
11/06/2019 176,27 177,15 174,20 174,62 -0,55% 1,67% 2.313.800
10/06/2019 175,95 176,16 174,05 175,58 +0,04% 1,20% 2.091.400
07/06/2019 175,63 176,00 173,28 175,51 +0,61% 1,55% 2.072.000
06/06/2019 174,78 176,06 174,09 174,45 -0,06% 1,13% 2.396.800
05/06/2019 175,68 175,77 173,09 174,55 -0,10% 1,53% 2.606.400
04/06/2019 174,03 175,36 170,56 174,73 +1,38% 2,76% 4.553.200
03/06/2019 172,00 176,81 170,56 172,36 +3,40% 3,63% 5.774.800
31/05/2019 168,06 168,87 166,68 166,70 -1,38% 1,30% 2.808.900
30/05/2019 169,44 170,05 168,20 169,04 -0,08% 1,09% 1.943.300
29/05/2019 168,00 169,76 167,33 169,18 +0,20% 1,45% 2.671.600
28/05/2019 171,56 172,77 168,76 168,85 -1,42% 2,34% 4.066.200
24/05/2019 172,62 173,77 171,09 171,28 -0,48% 1,55% 2.417.100
23/05/2019 171,34 173,06 170,49 172,11 +0,47% 1,50% 2.902.500
22/05/2019 169,35 172,05 168,58 171,30 +0,95% 2,05% 2.615.500
21/05/2019 169,77 170,02 168,53 169,69 +0,77% 0,88% 2.249.300
20/05/2019 168,68 170,40 168,15 168,39 -0,89% 1,33% 2.144.300
17/05/2019 169,27 171,24 169,11 169,91 -0,01% 1,26% 2.266.600
16/05/2019 169,40 172,02 169,34 169,92 +0,03% 1,58% 2.716.200
15/05/2019 167,23 170,60 166,30 169,87 +1,23% 2,57% 2.860.200
14/05/2019 167,68 169,72 167,30 167,81 +0,13% 1,44% 2.525.300
13/05/2019 169,24 169,60 167,17 167,60 -2,47% 1,44% 3.371.800
10/05/2019 172,46 172,46 168,44 171,85 -0,59% 2,33% 2.942.300
09/05/2019 171,24 173,18 169,44 172,87 +0,42% 2,18% 2.854.400
08/05/2019 173,50 175,50 171,70 172,15 -0,99% 2,19% 3.368.400
07/05/2019 175,14 176,41 172,50 173,87 -1,80% 2,23% 2.797.000
06/05/2019 175,49 177,24 173,88 177,06 -0,14% 1,91% 2.735.000
03/05/2019 176,93 177,77 176,47 177,31 +0,46% 0,73% 2.944.500
02/05/2019 176,06 178,30 174,30 176,50 +0,20% 2,27% 3.014.000